Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.

TYRA

Tyra Biosciences (TYRA)

Tyra Biosciences Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:TYRA
FechaHoraFuenteTítuloSímboloCompañía
09/05/202415:48Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TYRATyra Biosciences Inc
09/05/202415:46Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:TYRATyra Biosciences Inc
09/05/202415:12Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TYRATyra Biosciences Inc
09/05/202415:08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TYRATyra Biosciences Inc
09/05/202415:05PR Newswire (US)Tyra Biosciences Reports First Quarter 2024 Financial Results and HighlightsNASDAQ:TYRATyra Biosciences Inc
07/05/202415:34Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:TYRATyra Biosciences Inc
07/05/202415:05PR Newswire (US)Tyra Biosciences Announces Appointments of Susan Moran, M.D., M.S.C.E. and S. Michael Rothenberg, M.D., Ph.D. to its Board of DirectorsNASDAQ:TYRATyra Biosciences Inc
19/03/202415:05PR Newswire (US)Tyra Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and HighlightsNASDAQ:TYRATyra Biosciences Inc
27/02/202415:05PR Newswire (US)Tyra Biosciences to Present at Upcoming Investor ConferencesNASDAQ:TYRATyra Biosciences Inc
13/02/202415:36Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:TYRATyra Biosciences Inc
12/02/202415:46Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TYRATyra Biosciences Inc
07/02/202415:05PR Newswire (US)Tyra Biosciences to Present at Oppenheimer's 34th Annual Healthcare Life Sciences ConferenceNASDAQ:TYRATyra Biosciences Inc
02/02/202407:00PR Newswire (US)Tyra Biosciences, Inc. Announces $200 Million Private Placement FinancingNASDAQ:TYRATyra Biosciences Inc
01/02/202416:30PR Newswire (US)Tyra Biosciences Receives FDA Rare Pediatric Disease Designation for TYRA-300 for the Treatment of AchondroplasiaNASDAQ:TYRATyra Biosciences Inc
22/12/202308:00PR Newswire (US)Tyra Biosciences Doses First Patient with TYRA-200 and Provides Positive Updates on TYRA-300NASDAQ:TYRATyra Biosciences Inc
08/11/202315:05PR Newswire (US)Tyra Biosciences to Participate in 2023 Jefferies London Healthcare ConferenceNASDAQ:TYRATyra Biosciences Inc
07/11/202315:05PR Newswire (US)Tyra Biosciences Reports Third Quarter 2023 Financial Results and HighlightsNASDAQ:TYRATyra Biosciences Inc
21/09/202307:00PR Newswire (US)Tyra Biosciences Announces Oral Presentations on TYRA-300 for Achondroplasia at the ASBMR and ASHG 2023 Annual MeetingsNASDAQ:TYRATyra Biosciences Inc
12/09/202315:05PR Newswire (US)Tyra Biosciences to Participate at 2023 Cantor Global Healthcare ConferenceNASDAQ:TYRATyra Biosciences Inc
10/08/202315:05PR Newswire (US)Tyra Biosciences Reports Second Quarter 2023 Financial Results and HighlightsNASDAQ:TYRATyra Biosciences Inc
01/08/202307:54Dow Jones NewsTyra Biosciences Gets FDA Orphan Designation for TYRA-300 in AchondroplasiaNASDAQ:TYRATyra Biosciences Inc
01/08/202307:00PR Newswire (US)Tyra Biosciences Announces FDA Orphan Drug Designation for TYRA-300 for the Treatment of AchondroplasiaNASDAQ:TYRATyra Biosciences Inc
26/06/202318:30Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TYRATyra Biosciences Inc
23/06/202314:43Edgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:TYRATyra Biosciences Inc
02/06/202315:16Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TYRATyra Biosciences Inc
25/05/202307:00PR Newswire (US)Tyra Biosciences to Participate in Upcoming Investor ConferencesNASDAQ:TYRATyra Biosciences Inc
04/05/202315:23Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:TYRATyra Biosciences Inc
04/05/202315:05PR Newswire (US)Tyra Biosciences Reports First Quarter 2023 Financial Results and HighlightsNASDAQ:TYRATyra Biosciences Inc
17/04/202316:06Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:TYRATyra Biosciences Inc
17/04/202315:53Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:TYRATyra Biosciences Inc
 Showing the most relevant articles for your search:NASDAQ:TYRA

Su Consulta Reciente

Delayed Upgrade Clock